Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3794345 Title: MÉTHODE ASSOCIÉE À L'AGONISTE SIGMA-1 OPTIMISÉ DE SÉLECTION ET DE TRAITEMENT DE RÉPONDEUR

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
198029449
WO application number:
US2019033161
Type:
European patent granted for BE
Status:
Open
Publication number:
3794345
WO publication number:
WO2019222754
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
20/05/2019
Grant date:
26/02/2025
EP publication date:
24/03/2021
WO publication date:
21/11/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
26/02/2025
EP B1 publication date:
26/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
20/05/2039

Applicant

Name:
Anavex Life Sciences Corp.
Legal Form:
From:
26/02/2025
Address:
51 West 52nd Street 7th Floor, New York, NY 10019, United States (US)
To:

Inventor

1

Name:
MISSLING, Christopher U.
Legal Form:
Address:
New York, New York 10019, United States (US)

2

Name:
AFSHAR, Mohammad Michel
Legal Form:
Address:
75016 Paris, France (FR)

3

Name:
PARMENTIER, Frédéric
Legal Form:
Address:
94260 Fresnes, France (FR)

Priority

Priority patent number:
201862673369 P
Priority date:
18/05/2018
Priority country:
United States (US)

Classification

IPC or IDT classification:
G01N 33/49; C12Q 1/6883; C12Q 1/6876; C12Q 1/6886;

Publication

European Patent Bulletin

Issue number:
202509
Publication date:
26/02/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
02/06/2025
Annual fee number:
7
Annual fee amount:
110 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type